The store will not work correctly when cookies are disabled.
N'-(4-Bromobenzylidene)-2-methylbenzo[d]imidazo[2,1-b]thiazole-3-carbohydrazide
ID: ALA3763769
PubChem CID: 127042291
Max Phase: Preclinical
Molecular Formula: C18H13BrN4OS
Molecular Weight: 413.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2sc3ccccc3n2c1C(=O)N/N=C/c1ccc(Br)cc1
Standard InChI: InChI=1S/C18H13BrN4OS/c1-11-16(17(24)22-20-10-12-6-8-13(19)9-7-12)23-14-4-2-3-5-15(14)25-18(23)21-11/h2-10H,1H3,(H,22,24)/b20-10+
Standard InChI Key: SJGICQOINYBGGP-KEBDBYFISA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-0.4399 -1.9215 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.7408 -1.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3010 0.3704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2039 0.3704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6669 -1.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2688 -1.0186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7318 0.3704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5048 1.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1485 -1.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1672 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6810 1.1807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2225 1.5280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4974 2.7711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4550 3.3656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7929 3.5288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7854 5.0296 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8756 0.7334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0809 5.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0734 7.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3672 8.0474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3566 9.5474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0523 10.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7586 9.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7691 8.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0439 11.4882 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
2 6 2 0
3 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
4 12 2 0
5 9 2 0
15 16 1 0
13 14 2 0
13 15 1 0
8 13 1 0
7 17 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
22 25 1 0
16 18 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 413.30 | Molecular Weight (Monoisotopic): 411.9993 | AlogP: 4.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.67 | CX Basic pKa: 2.48 | CX LogP: 3.73 | CX LogD: 3.73 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.40 | Np Likeness Score: -2.14 |
References
1. Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.. (2016) Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 24 (6): [PMID:26867485] [10.1016/j.bmc.2016.01.059] |